New method promising for unborn babies with metabolic disorders

10/20/2009 | U.S. News & World Report

Researchers are conducting a trial on a new cord-blood transplant method that could treat potentially fatal metabolic conditions in unborn babies. The procedure involves injecting the fetuses with treated donor cells at 12 to 14 weeks into pregnancy. Performing the transplant before the baby is born increases the chance that the procedure would be effective, a transplant expert said.

View Full Article in:

U.S. News & World Report

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL